Clinical Research Detail Title Of Study This study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin monotherapy (i.e., treatment with a single drug) and have inadequate glycemic (blood sugar) control. Disease Condition Type 2 diabetes mellitus (T2DM) Phase of Trial Phase-3 Discipline Diabetology Start date of Trial 4/26/2010 Closing Date of Trial 4/26/2013 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]